End Stage Renal Disease on Dialysis Clinical Trials in Beijing, Beijing Municipality
2 recruitingBeijing, Beijing Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
End Stage Renal Disease on DialysisHyperphosphatemiaChronic Kidney Disease Requiring Chronic Dialysis
R1 Therapeutics168 enrolled26 locationsNCT06712654
Recruiting
Not Applicable
Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)
End Stage Renal Disease on Dialysis
Peking University People's Hospital34 enrolled1 locationNCT07111260